GlassScriptPhysician profile
Gregory M Scott
NPI 1225012990
$9,991.28
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,735 · 2020: $1,681 · 2021: $1,729 · 2022: $1,806 · 2023: $2,287 · 2024: $753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,040.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,322.90 | 2019-2024 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,956.70 | 2019-2024 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $1,166.78 | 2019-2024 | Tezspire, Fasenra, Breztri |
| Mylan Specialty L.P. | $676.76 | 2019-2024 | Yupelri |
| Grifols USA, LLC | $348.68 | 2019-2023 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $286.91 | 2023-2024 | Glassia |
| Mallinckrodt Hospital Products INC. | $255.62 | 2021-2023 | Acthar |
| Philips North America LLC | $234.04 | 2019-2024 | (Ak6) Vest Therapy |
| Electromed, INC. | $233.04 | 2022-2024 | Smartvest |
| Genentech USA, INC. | $206.61 | 2019-2020 | |
| Genzyme Corporation | $163.55 | 2022-2024 | |
| Harmony Biosciences LLC | $147.58 | 2020-2023 | Wakix |
| Regeneron Healthcare Solutions, INC. | $127.39 | 2021-2024 | Dupixent |
| Baxter Healthcare | $105.57 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Advanced Respiratory, INC | $104.66 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $96.34 | 2019 | |
| Janssen Pharmaceuticals, INC | $95.61 | 2021-2023 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $71.92 | 2019-2021 | |
| Vapotherm INC | $39.47 | 2021 | |
| Covis Pharma Gmbh | $38.09 | 2022 | |
| Amgen INC. | $37.74 | 2021-2023 | Tezspire |
| Vanda Pharmaceuticals INC. | $34.37 | 2020 | |
| Csl Behring | $34.20 | 2019 | |
| Tactile Systems Technology INC | $33.18 | 2024 | Flexitouch Plus, Entre Plus |
| La Jolla Pharmaceutical Company | $26.32 | 2024 | Giapreza |
| Jazz Pharmaceuticals INC. | $24.99 | 2021 | |
| Nabriva Therapeutics, Plc | $21.69 | 2021 | |
| Inogen, INC. | $20.45 | 2022 | |
| Insmed, INC. | $19.45 | 2021 | |
| Mayne Pharma Commercial LLC | $17.67 | 2019 | |
| Lilly USA, LLC | $16.00 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $14.51 | 2021 | |
| Circassia INC. | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.